The level is in the details: Why differences between direct-acting oral anticoagulants should be considered in the treatment of patients with epilepsy.

IF 6.6 1区医学 Q1 CLINICAL NEUROLOGY

Epilepsia Pub Date : 2024-10-26 DOI:10.1111/epi.18144

Hagar Cohen, Nahawand Bahash, Bruria Raccah, Ilan Matok, Dana Ekstein, Lee Goldstein, Yosef Kalish, Sara Eyal

引用次数: 0

查看原文本刊更多论文

细节决定水平：为什么在治疗癫痫患者时应考虑直接作用口服抗凝剂之间的差异？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Epilepsia 医学-临床神经学

CiteScore

10.90

自引率

10.70%

发文量

319

审稿时长

2-4 weeks

期刊介绍： Epilepsia is the leading, authoritative source for innovative clinical and basic science research for all aspects of epilepsy and seizures. In addition, Epilepsia publishes critical reviews, opinion pieces, and guidelines that foster understanding and aim to improve the diagnosis and treatment of people with seizures and epilepsy.